In gastric cancer, the ectopic expression of miR-101 significantly inhibits cell proliferation, migration and invasion by targeting enhancer of zeste homolog 2 (EZH2), Cyclooxygenase-2 (COX-2), Myeloid cell leukemia-1 (MCL-1) and Fos. Here, MCL1 is linked to gastric cancer.